Short answer
ACTUATE THERAPEUTICS, INC. (ACTU) filed an 8-K current report with the SEC on May 22, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders re-elected Aaron G.L. Fletcher and Jason Keyes to three-year Class II director terms ending at the 2029 annual meeting.
ACTUATE THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders re-elected Aaron G.L. Fletcher and Jason Keyes to three-year Class II director terms ending at the 2029 annual meeting
- Jason Keyes received 16,727,875 votes for and 32,397 withheld, indicating strong shareholder support
- Aaron G.L. Fletcher received 14,877,247 votes for and 1,883,025 withheld, reflecting comparatively higher withholding
- Crowe LLP ratified as independent auditor for fiscal 2026, with 18,571,817 votes for and 50,023 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACTUATE THERAPEUTICS, INC. 8-K filings
Get the next ACTU 8-K as it lands
Follow ACTU for push alerts, or ask the research agent what this filing means.